Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coya Therapeutics (COYA) Depreciation & Amortization - Total (2022 - 2025)

Coya Therapeutics' Depreciation & Amortization - Total history spans 4 years, with the latest figure at $6840.0 for Q3 2025.

  • For Q3 2025, Depreciation & Amortization - Total changed 0.01% year-over-year to $6840.0; the TTM value through Sep 2025 reached $27360.0, changed 0.0%, while the annual FY2024 figure was $27361.0, 0.0% changed from the prior year.
  • Depreciation & Amortization - Total for Q3 2025 was $6840.0 at Coya Therapeutics, roughly flat from $6840.0 in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $12455.0 in Q3 2022 and bottomed at $4033.0 in Q1 2022.
  • The 4-year median for Depreciation & Amortization - Total is $6840.0 (2022), against an average of $6840.2.
  • The largest YoY upside for Depreciation & Amortization - Total was 69.6% in 2023 against a maximum downside of 45.07% in 2023.
  • A 4-year view of Depreciation & Amortization - Total shows it stood at $6840.0 in 2022, then changed by 0.0% to $6840.0 in 2023, then changed by 0.0% to $6840.0 in 2024, then changed by 0.0% to $6840.0 in 2025.
  • Per Business Quant, the three most recent readings for COYA's Depreciation & Amortization - Total are $6840.0 (Q3 2025), $6840.0 (Q2 2025), and $6840.0 (Q1 2025).